Creative Essences Inc – FDA 483, Mar 25, 2025
Creative Essences Inc, a drug manufacturer in Santa Fe Springs, CA, was inspected by the FDA from March 19-25, 2025. The inspection revealed significant deficiencies across quality, laboratory, materials, facilities, equipment, and production systems, many of which were repeat observations from a previous 2020 inspection. Key issues include inadequate investigations, lack of proper quality control procedures, insufficient employee training, unconfirmed stability data for drug products, and unvalidated cleaning and manufacturing processes.
ID · 733e3cfd-7f1c-43a6-bdd7-d3ccfa7ecc66
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.